Showing results (41-50 of 153) with videos related to
Sort By:
Pageof 16
Seminars in Oncology|February 1, 2017
The role of rituximab and chemotherapy in aggressive B-cell lymphoma: A preliminary report of dose-adjusted EPOCH-RWyndham H Wilson, Martin Gutierrez, Paula O'Connor, et al.Seminars in Oncology|February 14, 2002
The role of rituximab and chemotherapy in aggressive B-cell lymphoma: a preliminary report of dose-adjusted EPOCH-RWyndham H Wilson, Martin Gutierrez, Paula O'Connor, et al.JCO Oncology Practice|June 6, 2022
Financial Toxicity, Symptom Burden, Illness Perceptions, and Communication Confidence in Cancer Clinical Trial ParticipantsSubha Perni, Chukwuma Azoba, Emily Gorton, et al.The Oncologist|February 15, 2005
Fear of deathRichard T Penson, Rosamund A Partridge, Muhammad A Shah, et al.The Oncologist|February 27, 2003
Living as a cancer surpriser: a doctor tells his storyKristine A Knuti, Robert H Wharton, Karen Levine Wharton, et al.Cancer|January 15, 2015
Patient navigation based on predictive modeling decreases no-show rates in cancer careSanja Percac-Lima, Patrick R Cronin, David P Ryan, et al.The Oncologist|April 17, 2019
Addressing the Financial Burden of Cancer Clinical Trial Participation: Longitudinal Effects of an Equity InterventionRyan D Nipp, Hang Lee, Emily Gorton, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 27, 2020
Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in OncologyOzge Gumusay, Pietro Paolo Vitiello, Chiara Wabl, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 2007
Trends in the use and role of biomarkers in phase I oncology trialsBernardo H L Goulart, Jeffrey W Clark, Homer H Pien, et al.Cancer Research|November 1, 2008
Insulin-like growth factor 2 is required for progression to advanced medulloblastoma in patched1 heterozygous miceRyan B Corcoran, Tal Bachar Raveh, Monique T Barakat, et al.Pageof 16